World
0%, Then 100% & Later 200%: Trump's Tariff Bomb On Generic Drugs Puts India's $10-Billion Exports At Risk
Published on
US President Donald Trump announced a two-year duty-free period for imported generic medicines, followed by steep tariffs of 100% and 200%, aimed at encouraging pharmaceutical manufacturing relocation to the US. This change significantly impacts countries like India, a major generic exporter.
